Sheng Xia

Prof. Sheng Xia

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
PGPeng Gao
Peng Gao
XMXianwei Ma
Xianwei Ma
MYMing Yuan
Ming Yuan
YYYulan Yi
Yulan Yi
GLGuoke Liu
Guoke Liu
HAHuazhang An
Huazhang An
Ubiquitination is one of the most prevalent protein posttranslational modifications. Here, we show that E3 ligase Nedd4l positively regulates antiviral immunity by catalyzing K29-linked cysteine ubiquitination of TRAF3. Deficiency of Nedd4l significantly impairs type I interferon and proinflammatory cytokine production induced by virus infection both in vitro and in vivo. Nedd4l deficiency inhibits virus-induced ubiquitination of TRAF3, the binding between TRAF3 and TBK1, and subsequent phosphorylation of TBK1 and IRF3. Nedd4l directly interacts with TRAF3 and catalyzes K29-linked ubiquitination of Cys56 and Cys124, two cysteines that constitute zinc fingers, resulting in enhanced association between TRAF3 and E3 ligases, cIAP1/2 and HECTD3, and also increased K48/K63-linked ubiquitination of TRAF3. Mutation of Cys56 and Cys124 diminishes Nedd4l-catalyzed K29-linked ubiquitination, but enhances association between TRAF3 and the E3 ligases, supporting Nedd4l promotes type I interferon production in response to virus by catalyzing ubiquitination of the cysteines in TRAF3.

1 November 2016 in International Immunopharmacology
Verified
Journal Article
Closed access
LCLu Cheng
Lu Cheng
HJHuimin Jin
Huimin Jin
YQYetao Qiang
Yetao Qiang
SWShuiyun Wu
Shuiyun Wu
CYCheng Yan
Cheng Yan
SXSheng Xia
Sheng Xia

13 January 2017 in RSC Advances
Verified
Journal Article
Open access
PDF file
MZM. Zhang
M. Zhang
XZX. Zhao
X. Zhao
ZFZ. Fang
Z. Fang
YNY. Niu
Y. Niu
JLJ. Lou
J. Lou
FDFengyi Du
Fengyi Du
Carbon quantum dots (CDs) as emerging carbon nano-materials have attracted tremendous attention in biomedical fields due to unique properties. In this study, hyaluronate (HA) and polyethylenimine (PEI) functionalized carbon dots (HP-CDs) were synthesized by a facile bottom-up method for tumor targeting and gene delivery. After HA modification, the HP-CDs exhibited superior dispersibility in water and good biocompatibility and were internalized readily into the cytoplasm of cancer via HA-receptor mediated endocytosis. Meanwhile, the HP-CDs with PEI functionalization were shown to have excellent gene condensation capability via electrostatic attraction and protective capacity by preventing nuclease degradation. By virtue of good photoluminescence properties, the HP-CDs as a gene carrier were successfully applied to intracellular imaging and gene delivery. Taken together, the resultant HP-CDs displayed great potential in tumor targeting, intracellular imaging and gene delivery.

24 July 2018 in Oncology Letters
Verified
Journal Article
Open access
PDF file
TXTengfei Xiao
Tengfei Xiao
SWShuiyun Wu
Shuiyun Wu
CYCheng Yan
Cheng Yan
CZChuanxiang Zhao
Chuanxiang Zhao
HJHuimin Jin
Huimin Jin
SXSheng Xia
Sheng Xia
Microbiota and its induced inflammation in colorectal mucosa have been considered risk factors for the development of colorectal carcinogenesis. Previous studies demonstrated that the coexisting elements of microbiota in the gut, such as short chain fatty acids (SCFAs) and lipopolysaccharides (LPS), which exhibited regulatory effects on the intestinal epithelial cells individually. Unfortunately, the association between butyrate and the toll‑like receptor (TLR) signaling pathway in the development of colon cancer is not fully elucidated. In the present study, by culturing human colon cancer SW480 cells or mouse colon cancer CT26 cells with butyrate and/or TLR4 ligand LPS in vitro, it was identified that butyrate suppressed the growth and promoted apoptosis of these cancer cells. Notably, the expression levels of TLR4 and CD14 were markedly increased on these butyrate‑treated cells, but not on LPS‑alone treated cells. Additionally, butyrate treatment induced the phosphorylation of extracellular signal‑regulated kinase, tumor protein 38, c‑Jun NH2‑terminal kinase and nuclear factor‑κB (NF‑κB) p65, and then promoted the pro‑inflammatory cytokine tumor necrosis factor‑α, but not interleukin 6 secretion in SW480 and CT26 cells. Therefore, butyrate treatment regulates the expression of TLR4, mitogen‑activated protein kinase and NF‑κB signal pathway activation and pro‑inflammatory response in vitro. Although the exact mechanisms have not been fully explored, these results suggested that butyrate and LPS‑TLR4 signaling mediated innate immunity in colon cancer cells through two distinct but inter‑regulated pathways. Thus, butyrate can further initiate innate immunity against tumor cells by upregulating the TLR4 expression and activation to preserve intestinal homeostasis.

6 October 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
JYJun Ye
Jun Ye
PYPeng Yang
Peng Yang
YYYili Yang
Yili Yang
SXSheng Xia
Sheng Xia
The molecules of the complement system connect the effectors of innate and adaptive immunity and play critical roles in maintaining homeostasis. Among them, the C1 complex, composed of C1q, C1r, and C1s (C1qr2s2), is the initiator of the classical complement activation pathway. While deficiency of C1s is associated with early-onset systemic lupus erythematosus and increased susceptibility to bacteria infections, the gain-of- function variants of C1r and C1s may lead to periodontal Ehlers Danlos syndrome. As C1s is activated under various pathological conditions and associated with inflammation, autoimmunity, and cancer development, it is becoming an informative biomarker for the diagnosis and treatment of a variety of diseases. Thus, more sensitive and convenient methods for assessing the level as well as activity of C1s in clinic samples are highly desirable. Meanwhile, a number of small molecules, peptides, and monoclonal antibodies targeting C1s have been developed. Some of them are being evaluated in clinical trials and one of the antibodies has been approved by US FDA for the treatment of cold agglutinin disease, an autoimmune hemolytic anemia. In this review, we will summarize the biological properties of C1s, its association with development and diagnosis of diseases, and recent progress in developing drugs targeting C1s. These progress illustrate that the C1s molecule is an effective biomarker and promising drug target.

29 September 2021 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
YJYalan Jiang
Yalan Jiang
ZTZehua Tao
Zehua Tao
HCHua Chen
Hua Chen
SXSheng Xia
Sheng Xia
The endoplasmic reticulum quality control (ERQC) system, including endoplasmic reticulum-associated degradation (ERAD), the unfolded protein response (UPR), and autophagy, presides over cellular protein secretion and maintains proteostasis in mammalian cells. As part of the immune system, a variety of proteins are synthesized and assembled correctly for the development, activation, and differentiation of immune cells, such as dendritic cells (DCs), macrophages, myeloid-derived-suppressor cells (MDSCs), B lymphocytes, T lymphocytes, and natural killer (NK) cells. In this review, we emphasize the role of the ERQC in these immune cells, and also discuss how the imbalance of ER homeostasis affects the immune response, thereby suggesting new therapeutic targets for immunotherapy.